Skip to main content

CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk

Publication ,  Conference
Rosenstock, J; Perkovic, V; Alexander, JH; Cooper, ME; Kahn, SE; Marx, N; Pencina, MJ; Toto, RD; Wanner, C; Zinman, B; Baanstra, D; Pfarr, E ...
Published in: DIABETES
June 1, 2017

Duke Scholars

Published In

DIABETES

EISSN

1939-327X

ISSN

0012-1797

Publication Date

June 1, 2017

Volume

66

Start / End Page

A344 / A344

Location

San Diego, CA

Publisher

AMER DIABETES ASSOC

Conference Name

77th Scientific Sessions of the American-Diabetes-Association

Related Subject Headings

  • Endocrinology & Metabolism
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rosenstock, J., Perkovic, V., Alexander, J. H., Cooper, M. E., Kahn, S. E., Marx, N., … Mcguire, D. K. (2017). CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk. In DIABETES (Vol. 66, pp. A344–A344). San Diego, CA: AMER DIABETES ASSOC.
Rosenstock, Julio, Vlado Perkovic, John H. Alexander, Mark Emmanuel Cooper, Steven E. Kahn, Nikolaus Marx, Michael J. Pencina, et al. “CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk.” In DIABETES, 66:A344–A344. AMER DIABETES ASSOC, 2017.
Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Kahn SE, Marx N, et al. CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk. In: DIABETES. AMER DIABETES ASSOC; 2017. p. A344–A344.
Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Kahn SE, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, George JT, Broedl UC, Woerle H-J, Von Eynatten M, Mcguire DK. CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk. DIABETES. AMER DIABETES ASSOC; 2017. p. A344–A344.

Published In

DIABETES

EISSN

1939-327X

ISSN

0012-1797

Publication Date

June 1, 2017

Volume

66

Start / End Page

A344 / A344

Location

San Diego, CA

Publisher

AMER DIABETES ASSOC

Conference Name

77th Scientific Sessions of the American-Diabetes-Association

Related Subject Headings

  • Endocrinology & Metabolism
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences